通过冠状动脉逆输液减少心脏病发作的大小
1Department of Cardiothoracic Surgery, Boston University Medical Center, MA.
Circulation
|November 1, 1992
概括
压力控制的间歇性冠状动脉鼻阻塞 (PICSO) 和L-谷氨酸可在紧急重血管化手术期间减少心脏损伤. 这种技术可以改善心脏功能,并在急性冠状动脉封闭后最大限度地减少组织损伤.
科学领域:
- 心血管外科心血管外科
- 缺血性心脏病是一种心脏病.
- 肌心保护 肌心保护
背景情况:
- 在手术重血管化过程中,急性冠状动脉封闭会导致严重的缺血损伤.
- 心肌保护策略对于在这些关键情况下尽量减少组织损伤至关重要.
研究的目的:
- 通过使用压力控制的间歇性冠状动脉鼻腔封闭 (PICSO) 来评估冠状动脉静脉逆的疗效.
- 评估PICSO与L-谷氨酸基质增强剂对减少缺血损伤的联合作用.
主要方法:
- 使用了手术冠状动脉封闭的猪模型.
- 组接受了PICSO单独,PICSO与氧化血液,PICSO与L-谷氨酸,或没有干预 (未经修改).
- 测量包括墙壁运动得分,死与风险面积比率和组织酸 (pH).
主要成果:
- 与未经修改组相比,单独使用PICSO和与L-氨酸结合使用显著改善了墙壁运动得分.
- 两组PICSO都显示了显著较低的死与风险比率的区域.
- 在用PICSO和L-谷氨酸盐治疗的心脏中,组织酸明显减少.
结论:
- 用PICSO进行冠状动脉逆输液有效降低缺血性损伤.
- 将PICSO与L-谷氨酸相结合,在手术重血管化过程中进一步增强了心肌保护.
- 这些发现支持PICSO作为心肌保护的宝贵补充剂.
相关概念视频
Anatomy of the Heart
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


